SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-22-017633
Filing Date
2022-07-25
Accepted
2022-07-22 17:46:14
Documents
6

Document Format Files

Seq Description Document Type Size
1 pbyi20220718_s3.htm S-3 154883
2 ex_398206.htm EX-5.1 13551
3 ex_398207.htm EX-10.1 206957
4 ex_398208.htm EX-23.2 2180
5 ex_398209.htm EX-FILING FEES 17550
6 lw01.jpg GRAPHIC 4218
  Complete submission text file 0001437749-22-017633.txt   402136
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266306 | Film No.: 221100673
SIC: 2834 Pharmaceutical Preparations